NFKB1 and cancer: FBXW2 has been reported to reduce expression of several proteins associated with malignant tumor states, such as β-catenin [5], SKP2 [6], NF-κB p65 [8] and EGFR [7], which contribute to cancer stemness, tumorigenesis and metastasis [8, 37–39].